Takeda Oncology

Featured Drug Company Program

Takeda Oncology’s Ninlaro 1Point program offers comprehensive services that can assist patients with the financial burden and other day-to-day needs associated with Ninlaro (ixazomib) treatment. Ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least 1 previous therapy. [ Read More ]

Tesaro

Featured Drug Company Program

TOGETHER with TESARO is Tesaro’s Patient Resource Program dedicated to supporting patients living with cancer. The program offers solutions for medication access and affordability. [ Read More ]

Teva Oncology

Featured Drug Company Program

The Teva Cares Foundation offers access to oncology medications from Teva Oncology through the Teva Cares Foundation Patient Assistance Program and Teva Comprehensive Oncology Reimbursement Expertise (CORE) program. [ Read More ]